EN DE
STOCK COMPARISON

Honliv Healthcare Management vs HCA Healthcare: Fair Value & Quality

Both stocks run through our valuation models. Here is how Honliv Healthcare Management (9906) and HCA Healthcare (HCA) compare, as of Aug 10, 2026.

As of Aug 10, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Honliv Healthcare Management trades at HK$1.56 versus a fair value of HK$1.14 (-27%), while HCA Healthcare trades at $413 versus $555 (+34%).
Honliv Healthcare Management
9906.HK · HKD · Health Care
-27%
upside to fair value
overvalued
PriceHK$1.56
Fair ValueHK$1.14
Quality60/100
HCA Healthcare
HCA · USD · Health Care
+34%
upside to fair value
undervalued
Price$413
Fair Value$555
Quality70/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Honliv Healthcare ManagementHCA Healthcare
Valuation
78.0×P/E (TTM)12.5×
1.34×P/S (TTM)1.06×
1.63×P/B—
7.6×EV/EBITDA7.8×
—PEG1.18×
—Dividend yield0.8%
—Dividend per share$2.94
Profitability
1%Net margin9%
1%Operating margin15%
2%Return on equity136%
1%Return on assets12%
Growth
-17%Revenue growth (YoY)4%
8.2%Avg. growth/yr (3Y)7.9%
7.7%Avg. growth/yr (5Y)8.0%
Balance & size
0.02×Debt / equity—
$119MMarket cap$81B
mixedGrowth qualityhealthy

HCA Healthcare leads: 2 to 8 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Honliv Healthcare Managementof which business quality 61 · market factors 55 HCA Healthcareof which business quality 66 · market factors 46
ProfitabilityMargins and returns on capital today
34
76
Quality GrowthAre margins and returns improving?
39
61
CashflowEarnings quality: real cash, not paper profit
45
62
Fin. StrengthBalance sheet, leverage, solvency risk
77
39
InvestmentDisciplined investing over empire-building
89
75
Low VolatilityCalm price path (market factor)
100
59
MomentumPrice trend over the last 3–12 months (market factor)
39
38
52W MomentumDistance to the 52-week high (market factor)
31
44
Net IssuanceBuybacks instead of dilution
100
100

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Honliv Healthcare Management

DCF ModelsHK$1.45
Earnings-BasedHK$0.67
MultiplesHK$1.32
Asset-BasedHK$0.64
Growth DCFHK$1.26
Economic ProfitHK$0.86
Growth EarningsHK$1.00

19 of 24 models see the stock below the current price.

HCA Healthcare

DCF Models$546
Earnings-Based$289
Dividend Discount$53.85
Multiples$673
Growth DCF$540
Economic Profit$419
Growth Earnings$506

6 of 23 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Honliv Healthcare Management
Bear HK$0.86Fair Value HK$1.14Bull HK$1.43
HK$1.56 = current price (white tick)
HCA Healthcare
Bear $270Fair Value $555Bull $841
$413 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Honliv Healthcare Management · Health Care

Quality score60 · above median
Fair value upside-27% · above median

HCA Healthcare · Health Care

Quality score70 · Top 25%
Fair value upside+34% · Top 25%

Bottom line

As of Aug 10, 2026, Fair Value Calculator sees HCA Healthcare as the more attractively valued of the two: Honliv Healthcare Management trades at HK$1.56 versus a fair value of HK$1.14 (-27%), while HCA Healthcare trades at $413 versus $555 (+34%).

HCA Healthcare has the higher quality score (70/100).

See the full analysis →
Honliv Healthcare Management · HCA Healthcare

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Honliv Healthcare Management

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to HCA Healthcare

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.